Evercore ISI Reaffirms Their Buy Rating on Merck & Company (MRK)
In a report released yesterday, Umer Raffat from Evercore ISI maintained a Buy rating on Merck & Company (MRK – Research Report). The ...
Zacks.com on MSN11h
AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe Update
AstraZeneca’s AZN fourth-quarter 2024 core earnings of $1.05 per American depositary share (“ADS”) missed the Zacks Consensus ...